β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is a central therapeutic target in Alzheimer’s disease, as it catalyzes the rate-limiting step in amyloid-β production. The gene discussed is BACE1; the disease is early-onset autosomal dominant Alzheimer disease.